$MMND
MASTERMIND, INC.

2024 Q2 Form 10-Q Financial Statement

#000147793224003007 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $806.0K $804.9K $398.5K
YoY Change -38.91% -29.21% -61.75%
Cost Of Revenue $261.3K $316.8K $298.8K
YoY Change -51.01% -25.49% -28.95%
Gross Profit $544.8K $488.1K $99.64K
YoY Change -30.7% -31.43% -83.96%
Gross Profit Margin 67.59% 60.64% 25.01%
Selling, General & Admin $470.9K $431.2K $659.9K
YoY Change -18.8% -22.09% 14.34%
% of Gross Profit 86.45% 88.34% 662.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.158K $3.497K $3.610K
YoY Change -9.87% -39.53%
% of Gross Profit 0.58% 0.72% 3.62%
Operating Expenses $470.9K $431.2K $659.9K
YoY Change -18.8% -22.09% 14.34%
Operating Profit $73.84K $56.90K -$560.2K
YoY Change -64.18% -64.06% -1368.53%
Interest Expense $6.890K $9.180K $17.15K
YoY Change -31.1% 128.93% 1250.39%
% of Operating Profit 9.33% 16.13%
Other Income/Expense, Net $6.890K $9.176K
YoY Change 5.05% 149.08%
Pretax Income $80.73K $66.07K -$543.1K
YoY Change -62.04% -59.21% -1575.0%
Income Tax $22.19K $18.42K -$39.80K
% Of Pretax Income 27.48% 27.88%
Net Earnings $58.54K $47.65K -$503.3K
YoY Change -62.29% -59.66% 3584.87%
Net Earnings / Revenue 7.26% 5.92% -126.31%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 34.51M shares 34.51M shares
Diluted Shares Outstanding 34.51M shares 34.51M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $694.3K $761.1K $1.137M
YoY Change -41.66% -45.17% -33.62%
Cash & Equivalents $694.3K $761.1K $1.137M
Short-Term Investments
Other Short-Term Assets $40.72K $56.50K $29.20K
YoY Change -49.1% -27.08% -62.31%
Inventory
Prepaid Expenses
Receivables $219.3K $212.9K $1.934M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.154M $3.013M $3.100M
YoY Change -12.27% -16.45% -8.59%
LONG-TERM ASSETS
Property, Plant & Equipment $31.24K $34.40K $37.90K
YoY Change -18.83% -11.45% -7.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $31.24K $34.40K $37.89K
YoY Change -18.83% -11.45% -7.23%
TOTAL ASSETS
Total Short-Term Assets $3.154M $3.013M $3.100M
Total Long-Term Assets $31.24K $34.40K $37.89K
Total Assets $3.185M $3.048M $3.138M
YoY Change -12.34% -16.39% -8.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $176.0K $65.03K $213.1K
YoY Change 60.01% -55.32% 156.34%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $235.4K $177.6K $334.3K
YoY Change -38.32% -64.87% -26.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $235.4K $177.6K $334.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $498.5K $419.7K $558.0K
YoY Change -26.62% -50.42% -25.8%
SHAREHOLDERS EQUITY
Retained Earnings $2.589M $2.531M $2.483M
YoY Change -9.36% -6.32% -3.88%
Common Stock $34.51K $34.51K $34.51K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.687M $2.628M $2.580M
YoY Change
Total Liabilities & Shareholders Equity $3.185M $3.048M $3.138M
YoY Change -12.34% -16.39% -8.58%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $58.54K $47.65K -$503.3K
YoY Change -62.29% -59.66% 3584.87%
Depreciation, Depletion And Amortization $3.158K $3.497K $3.610K
YoY Change -9.87% -39.53%
Cash From Operating Activities -$66.79K -$375.9K -$253.2K
YoY Change -66.61% 16.57% 1236.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $4.830K
YoY Change -100.0% 41.23%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$4.830K
YoY Change -100.0% 41.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -66.79K -$375.9K -253.2K
Cash From Investing Activities 0.000 $0.00 -4.830K
Cash From Financing Activities
Net Change In Cash -66.79K -$375.9K -258.1K
YoY Change -66.61% 15.78% 1053.69%
FREE CASH FLOW
Cash From Operating Activities -$66.79K -$375.9K -$253.2K
Capital Expenditures $0.00 $0.00 $4.830K
Free Cash Flow -$66.79K -$375.9K -$258.1K
YoY Change -66.61% 15.35% 1053.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1982877 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3100466 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
56501 usd
CY2024Q1 us-gaap Depreciation
Depreciation
3497 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
18422 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41473 usd
CY2024Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-302948 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-41865 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
62409 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
212856 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001088638
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34505520 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34505520 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34505520 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Entity File Number
EntityFileNumber
000-26533
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
MASTERMIND, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3807447
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2221 Peachtree Rd. NE
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite D-134
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30309
CY2024Q1 dei City Area Code
CityAreaCode
678
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
420-4000
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34505520 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
761064 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137010 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
254329 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1679929 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29198 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3013298 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34401 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37898 usd
CY2024Q1 us-gaap Assets
Assets
3047699 usd
CY2023Q4 us-gaap Assets
Assets
3138364 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
65026 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213120 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
112553 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
121196 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
177579 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334316 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
242113 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
223691 usd
CY2024Q1 us-gaap Liabilities
Liabilities
419692 usd
CY2023Q4 us-gaap Liabilities
Liabilities
558007 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
34506 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
34506 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62865 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62865 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2530636 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2482986 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2628007 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2580357 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3047699 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3138364 usd
CY2024Q1 us-gaap Revenues
Revenues
804900 usd
CY2023Q1 us-gaap Revenues
Revenues
1136958 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
316786 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
425141 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
488114 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
711817 usd
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
100725 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
210625 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
44104 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
67183 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
194723 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
186944 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
91666 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88760 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
431218 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
553512 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
56896 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
158305 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
9176 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
4013 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-329 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9176 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3684 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66072 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161989 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18422 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43871 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
47650 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
118118 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2580357 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
47650 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2628007 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2680676 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
118118 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2798794 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
47650 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118118 usd
CY2023Q1 us-gaap Depreciation
Depreciation
3875 usd
CY2024Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2023Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
329 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
43871 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-217956 usd
CY2023Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-279433 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27303 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-148094 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8643 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11857 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-375946 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-322509 usd
CY2024Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
1200 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3408 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2208 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-375946 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-324717 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137010 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1712771 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
761064 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1388054 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
28 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Deposit Liability Uninsured
DepositLiabilityUninsured
250000 usd
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
405000 usd
CY2024Q1 mmnd Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
27000 usd
CY2023Q1 mmnd Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
15000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34505520 shares

Files In Submission

Name View Source Status
0001477932-24-003007-index-headers.html Edgar Link pending
0001477932-24-003007-index.html Edgar Link pending
0001477932-24-003007.txt Edgar Link pending
0001477932-24-003007-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmnd-20240331.xsd Edgar Link pending
mmnd_10q.htm Edgar Link pending
mmnd_ex311.htm Edgar Link pending
mmnd_ex312.htm Edgar Link pending
mmnd_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mmnd_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
mmnd-20240331_cal.xml Edgar Link unprocessable
mmnd-20240331_def.xml Edgar Link unprocessable
mmnd-20240331_lab.xml Edgar Link unprocessable
mmnd-20240331_pre.xml Edgar Link unprocessable